Shares of Landmark Infrastructure (NASDAQ:LMRK) reached a new 52-week high and low during mid-day trading on Friday . The company traded as low as $13.75 and last traded at $13.85, with a volume of 1179 shares changing hands. The stock had previously closed at $14.05.
A number of analysts have issued reports on LMRK shares. B. Riley set a $20.00 target price on Landmark Infrastructure and gave the company a “buy” rating in a report on Tuesday, February 20th. Robert W. Baird set a $19.00 target price on Landmark Infrastructure and gave the company a “buy” rating in a report on Thursday, February 15th. TheStreet lowered Landmark Infrastructure from a “b” rating to a “c+” rating in a report on Wednesday, May 16th. Zacks Investment Research lowered Landmark Infrastructure from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 25th. Finally, BidaskClub raised Landmark Infrastructure from a “sell” rating to a “hold” rating in a report on Wednesday, February 7th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company’s stock. Landmark Infrastructure currently has a consensus rating of “Hold” and an average price target of $19.10.
Top 5 Heal Care Stocks To Buy Right Now: ProQR Therapeutics N.V.(PRQR)
- [By Keith Speights]
Shares of ProQR Therapeutics N.V. (NASDAQ:PRQR) were up 16% as of 3:48 p.m. EDT on Monday. ProQR didn’t report any new announcements, but the biotech’s update last Wednesday from a phase 1/2 clinical study — of RNA medicine QR-110, in treating Leber congenital amaurosis type 10 (LCA10) — still had investors fired up.
- [By Cory Renauer]
ProQR (NASDAQ:PRQR) is developing QR-110 to treat patients with a mutation on the same gene as EDIT-101 but in a much different manner. QR-110 would require repeat injections right in the eyes to help a mutated gene produce functional copies of the CEP290 protein, while EDIT-101 is designed to repair the gene and provide a permanent solution with a single treatment.
- [By Brian Feroldi]
After reporting data from a phase 1/2 clinical trial, shares of ProQR Therapeutics N.V. (NASDAQ:PRQR), a clinical-stage biotech focused on RNA medicines that treat rare genetic diseases, rose 70% as of 12:13 p.m. EDT on Wednesday.
- [By Logan Wallace]
Press coverage about ProQR Therapeutics (NASDAQ:PRQR) has trended somewhat positive this week, Accern reports. The research firm identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ProQR Therapeutics earned a media sentiment score of 0.24 on Accern’s scale. Accern also gave media coverage about the biopharmaceutical company an impact score of 45.796201369253 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
- [By Stephan Byrd]
ProQR Therapeutics (NASDAQ:PRQR) announced its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.27) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.42) by $0.15, Zacks reports.
Top 5 Heal Care Stocks To Buy Right Now: Glu Mobile Inc.(GLUU)
- [By Keith Noonan]
Shares of Glu Mobile (NASDAQ:GLUU) gained 20.7% in January, according to data from S&P Global Market Intelligence. Recovery for the broader market early in 2019 and some encouraging analyst coverage propelled Glu stock to a 10-year high.
- [By Rick Munarriz]
Sirius XM Holdings (NASDAQ:SIRI), Glu Mobile (NASDAQ:GLUU), Fitbit (NYSE:FIT), GoPro (NASDAQ:GPRO), Zynga (NASDAQ:ZNGA), Rite Aid (NYSE:RAD), and Groupon (NASDAQ:GRPN) are some of the big names with low prices that I’m watching these days. Let’s take a closer look at these seven stocks trading for $7 or less.
- [By Logan Wallace]
Glu Mobile Inc. (NASDAQ:GLUU) saw a significant growth in short interest in the month of June. As of June 15th, there was short interest totalling 3,239,484 shares, a growth of 60.8% from the May 31st total of 2,015,180 shares. Based on an average daily volume of 2,953,150 shares, the days-to-cover ratio is currently 1.1 days. Approximately 3.0% of the shares of the company are sold short.
Top 5 Heal Care Stocks To Buy Right Now: Asia Pacific Wire & Cable Corporation Limited(APWC)
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Zoe's Kitchen, Inc. (NYSE: ZOES) fell 27.8 percent to $10.45 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter. The company also lowered its FY18 sales outlook from $358million-$368 million to $345 million-$352 million.
Hibbett Sports, Inc. (NASDAQ: HIBB) shares fell 15.6 percent to $24.50 in pre-market trading after the company reported weaker-than-expected results for its first quarter.
Rockwell Medical, Inc. (NASDAQ: RMTI) fell 15.5 percent to $5.02 in the pre-market trading session after the company disclosed that its President and CEO Robert Chioini was terminated.
BG Staffing Inc (NYSE: BGSF) shares fell 12.7 percent to $19.00 in pre-market trading after reporting a common stock offering.
8×8, Inc. (NASDAQ: EGHT) fell 9.3 percent to $20.00 in pre-market trading after reporting downbeat quarterly earnings.
Asia Pacific Wire & Cable Corporation Limited (NASDAQ: APWC) fell 7.7 percent to $2.35 in pre-market trading after rising 3.88 percent on Thursday.
Gap, Inc. (NYSE: GPS) shares fell 7.5 percent to $30.49 in pre-market trading after the company posted downbeat earnings for its first quarter on Thursday. Comps were up 1 percent in the quarter.
California Resources Corporation (NYSE: CRC) fell 6.4 percent to $33.91 in pre-market trading.
Buckle Inc (NYSE: BKE) fell 4.9 percent to $24.50 in pre-market trading following weak quarterly sales.
China Rapid Finance Limited (NYSE: XRF) shares fell 4.9 percent to $3.13 in pre-market trading after climbing 11.53 percent on Thursday.
Ross Stores, Inc. (NASDAQ: ROST) fell 4.8 percent to $78.98 in pre-market trading. Ross Stores reported upbeat earnings for its first quarter, but issued weak forecast for the current quarter.
Callon Petroleum Company (NYSE: CPE) shares fell 4.7 percent to $11.90 in pre-market trading after the company reported pricing of common
Top 5 Heal Care Stocks To Buy Right Now: B. Riley Financial, Inc.(RILY)
- [By Logan Wallace]
B. Riley Financial (NASDAQ:RILY) will post its quarterly earnings results after the market closes on Tuesday, March 5th.
RILY opened at $17.17 on Monday. B. Riley Financial has a fifty-two week low of $13.60 and a fifty-two week high of $23.70. The company has a debt-to-equity ratio of 5.54, a current ratio of 4.34 and a quick ratio of 4.34. The firm has a market cap of $446.11 million, a PE ratio of 10.77 and a beta of 1.27.
- [By Stephan Byrd]
Broadridge Financial Solutions (NYSE: BR) and B. Riley Financial (NASDAQ:RILY) are both business services companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends.
- [By WWW.GURUFOCUS.COM]
For the details of Standard General L.P.’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Standard+General+L.P.
These are the top 5 holdings of Standard General L.P.National CineMedia Inc (NCMI) – 12,576,000 shares, 60.53% of the total portfolio. New PositionTime Inc (TIME) – 3,181,424 shares, 29.62% of the total portfolio. Turning Point Brands Inc (TPB) – 305,319 shares, 3.58% of the total portfolio. Shares added by 189.90%CafePress Inc (PRSS) – 2,500,000 shares, 3.12% of the total portfolio. New PositionB. Riley Financial Inc (RILY) – 167,736 shares, 1.97% of the total portfoli
- [By Motley Fool Transcribers]
B. Riley Financial Inc (NASDAQ:RILY)Q4 2018 Earnings Conference CallMarch 05, 2019, 4:30 p.m. ET
Prepared Remarks Questions and Answers Call Participants
Top 5 Heal Care Stocks To Buy Right Now: RetailMeNot, Inc.(SALE)
- [By Stephan Byrd]
Headlines about RetailMeNot (NASDAQ:SALE) have been trending somewhat positive this week, according to Accern Sentiment. The research group rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. RetailMeNot earned a news sentiment score of 0.18 on Accern’s scale. Accern also gave news headlines about the technology company an impact score of 45.6302865418039 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.